Compare ENDP to:
After Hours: 22.5955 N/A (N/A) 1:17pm ET
| Last Trade: | 22.60 |
|---|---|
| Trade Time: | Nov 27 |
| Change: | |
| Prev Close: | 22.89 |
| Open: | 22.33 |
| Bid: | 22.00 x 300 |
| Ask: | N/A |
| 1y Target Est: | 26.03 |
| Day's Range: | 22.26 - 22.68 |
|---|---|
| 52wk Range: | 15.75 - 26.14 |
| Volume: | 301,836 |
| Avg Vol (3m): | 1,434,380 |
| Market Cap: | 2.65B |
| P/E (ttm): | 13.41 |
| EPS (ttm): | 1.69 |
| Div & Yield: | N/A (N/A) |
| Wed, Nov 25 | Prospecting for Stocks: Novartisat Motley Fool |
| Wed, Nov 25 | 12 Companies With Ironclad Balance Sheetsat Motley Fool |
| Fri, Nov 13 | ENDO PHARMACEUTICALS HOLDINGS INC Files SEC form 8-K, Other Events, Financial Statements and ExhibitsEDGAR Online |
| Thu, Nov 12 | Endo paying $23M to settle patent dispute with LecTecat bizjournals.com |
| Wed, Nov 11 | UPDATE - Endo and LecTec settle patent disputeat Reuters |
| Wed, Nov 11 | Endo paying $23 million to settle patent disputeAP |
| Wed, Nov 11 | Endo Pharmaceuticals and LecTec Settle Patent DisputePR Newswire |
| Fri, Nov 6 | Endo makes first milestone payment to Bioniche for bladder cancer drugat bizjournals.com |
| Fri, Nov 6 | UPDATE - Bioniche gets $6 mln milestone payment from Endo Pharmaat Reuters |
| Thu, Nov 5 | Indian Pharmaceutical Stock Picks From Citi Investment Research: The Sub Continent Goes Global WIth Drug Manufacturing PartnershipsWall Street Transcript |
Quotes delayed, except where indicated otherwise.
Delay times are 15 mins for NASDAQ, NYSE and Amex.See also delay times for other exchanges.